Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Stomach Neoplasms 40 Carcinoma, Non-Small-Cell Lung 35 Lung Neoplasms 13 Neoplasms 12 Adenocarcinoma 11 Neoplasm Metastasis 10 Colorectal Neoplasms 9 Esophageal Neoplasms 7 Carcinoma, Hepatocellular 7 Colonic Neoplasms 5 Carcinoma, Renal Cell 5 Breast Neoplasms 5 Adenocarcinoma Of Esophagus 5 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Rectal Neoplasms 3 Melanoma 3 Liver Neoplasms 3 Carcinoma, Transitional Cell 3 Biliary Tract Neoplasms 3 Ureteral Neoplasms 2 Thymoma 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Sarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Non-small Cell Lung Cancer Metastatic 2 Metastatic Gastric Adenocarcinoma 2

Interventions

Pemetrexed 40 Cisplatin 35 pembrolizumab 21 Nivolumab 17 Carboplatin 16 Ipilimumab 13 Gemcitabine 10 Cyclophosphamide 9 fludarabine 6 durvalumab 6 Bevacizumab 6 Radiotherapy, Intensity-Modulated 4 LMB-100 4 Drug Therapy 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 spartalizumab 3 olaparib 3 niraparib 3 atezolizumab 3 anetumab ravtansine 3 amatuximab 3 Vinorelbine 3 Paclitaxel 3 Oxaliplatin 3 Imatinib Mesylate 3 Fluorouracil 3 Cerebral Decortication 3 Blood Specimen Collection 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Ramucirumab × Clear all

NCT03560973 2025-03-13

RAMES

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡